Chlorine in PDB 2f8i: Human Transthyretin (Ttr) Complexed with Benzoxazole
Protein crystallography data
The structure of Human Transthyretin (Ttr) Complexed with Benzoxazole, PDB code: 2f8i
was solved by
S.K.Palaninathan,
N.N.Mohamedmohaideen,
J.C.Sacchettini,
J.W.Kelly,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.36 /
1.54
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
43.072,
84.690,
64.731,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
21.7 /
24.6
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Human Transthyretin (Ttr) Complexed with Benzoxazole
(pdb code 2f8i). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Human Transthyretin (Ttr) Complexed with Benzoxazole, PDB code: 2f8i:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 2f8i
Go back to
Chlorine Binding Sites List in 2f8i
Chlorine binding site 1 out
of 4 in the Human Transthyretin (Ttr) Complexed with Benzoxazole
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Human Transthyretin (Ttr) Complexed with Benzoxazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1002
b:22.4
occ:0.50
|
CL16
|
A:2051002
|
0.0
|
22.4
|
0.5
|
C15
|
A:2051002
|
1.8
|
20.0
|
0.5
|
C14
|
A:2051002
|
2.7
|
20.9
|
0.5
|
C10
|
A:2051002
|
2.7
|
20.6
|
0.5
|
C8
|
A:2051002
|
2.9
|
21.2
|
0.5
|
O17
|
A:2051002
|
3.2
|
20.9
|
0.5
|
N17
|
A:2051002
|
3.9
|
20.6
|
0.5
|
C13
|
A:2051002
|
4.0
|
20.8
|
0.5
|
C11
|
A:2051002
|
4.0
|
19.6
|
0.5
|
C3
|
A:2051002
|
4.2
|
20.4
|
0.5
|
C12
|
A:2051002
|
4.5
|
20.2
|
0.5
|
C2
|
A:2051002
|
4.6
|
21.2
|
0.5
|
|
Chlorine binding site 2 out
of 4 in 2f8i
Go back to
Chlorine Binding Sites List in 2f8i
Chlorine binding site 2 out
of 4 in the Human Transthyretin (Ttr) Complexed with Benzoxazole
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Human Transthyretin (Ttr) Complexed with Benzoxazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1002
b:20.0
occ:0.50
|
CL17
|
A:2051002
|
0.0
|
20.0
|
0.5
|
C11
|
A:2051002
|
1.8
|
19.6
|
0.5
|
C10
|
A:2051002
|
2.7
|
20.6
|
0.5
|
C12
|
A:2051002
|
2.8
|
20.2
|
0.5
|
C8
|
A:2051002
|
3.0
|
21.2
|
0.5
|
N17
|
A:2051002
|
3.1
|
20.6
|
0.5
|
C
|
A:ALA108
|
3.7
|
11.1
|
1.0
|
CB
|
A:ALA108
|
3.7
|
11.3
|
1.0
|
N
|
A:ALA109
|
3.7
|
10.0
|
1.0
|
O
|
A:ALA108
|
3.7
|
11.5
|
1.0
|
C
|
A:ALA109
|
3.8
|
9.8
|
1.0
|
N
|
A:LEU110
|
3.8
|
9.7
|
1.0
|
CA
|
A:ALA109
|
3.8
|
9.7
|
1.0
|
O17
|
A:2051002
|
3.9
|
20.9
|
0.5
|
CB
|
A:LEU110
|
4.0
|
10.4
|
1.0
|
O
|
A:SER117
|
4.0
|
12.2
|
1.0
|
C15
|
A:2051002
|
4.0
|
20.0
|
0.5
|
C13
|
A:2051002
|
4.1
|
20.8
|
0.5
|
C2
|
A:2051002
|
4.1
|
21.2
|
0.5
|
O
|
A:ALA109
|
4.3
|
11.2
|
1.0
|
CA
|
A:ALA108
|
4.4
|
11.2
|
1.0
|
CG2
|
A:THR119
|
4.4
|
13.6
|
1.0
|
N
|
A:THR119
|
4.4
|
11.0
|
1.0
|
CA
|
A:LEU110
|
4.5
|
9.8
|
1.0
|
C3
|
A:2051002
|
4.5
|
20.4
|
0.5
|
C14
|
A:2051002
|
4.6
|
20.9
|
0.5
|
CA
|
A:THR118
|
4.6
|
12.0
|
1.0
|
C
|
A:SER117
|
4.6
|
12.6
|
1.0
|
C
|
A:THR118
|
4.8
|
12.3
|
1.0
|
N
|
A:THR118
|
4.9
|
11.2
|
1.0
|
CB
|
A:THR119
|
4.9
|
13.3
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 2f8i
Go back to
Chlorine Binding Sites List in 2f8i
Chlorine binding site 3 out
of 4 in the Human Transthyretin (Ttr) Complexed with Benzoxazole
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Human Transthyretin (Ttr) Complexed with Benzoxazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1001
b:21.8
occ:0.50
|
CL16
|
B:2051001
|
0.0
|
21.8
|
0.5
|
C15
|
B:2051001
|
1.8
|
19.6
|
0.5
|
C14
|
B:2051001
|
2.7
|
20.3
|
0.5
|
C10
|
B:2051001
|
2.8
|
20.3
|
0.5
|
C8
|
B:2051001
|
3.0
|
20.7
|
0.5
|
O17
|
B:2051001
|
3.2
|
21.0
|
0.5
|
N17
|
B:2051001
|
4.0
|
20.2
|
0.5
|
C13
|
B:2051001
|
4.0
|
20.8
|
0.5
|
C11
|
B:2051001
|
4.0
|
19.3
|
0.5
|
C3
|
B:2051001
|
4.2
|
21.0
|
0.5
|
C12
|
B:2051001
|
4.5
|
20.2
|
0.5
|
C2
|
B:2051001
|
4.6
|
20.8
|
0.5
|
CD2
|
B:LEU110
|
4.9
|
13.5
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 2f8i
Go back to
Chlorine Binding Sites List in 2f8i
Chlorine binding site 4 out
of 4 in the Human Transthyretin (Ttr) Complexed with Benzoxazole
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Human Transthyretin (Ttr) Complexed with Benzoxazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1001
b:19.5
occ:0.50
|
CL17
|
B:2051001
|
0.0
|
19.5
|
0.5
|
C11
|
B:2051001
|
1.8
|
19.3
|
0.5
|
C12
|
B:2051001
|
2.7
|
20.2
|
0.5
|
C10
|
B:2051001
|
2.7
|
20.3
|
0.5
|
C8
|
B:2051001
|
3.1
|
20.7
|
0.5
|
N17
|
B:2051001
|
3.3
|
20.2
|
0.5
|
CB
|
B:ALA108
|
3.7
|
14.4
|
1.0
|
C
|
B:ALA108
|
3.7
|
13.0
|
1.0
|
N
|
B:LEU110
|
3.7
|
11.2
|
1.0
|
N
|
B:ALA109
|
3.7
|
12.4
|
1.0
|
O
|
B:ALA108
|
3.7
|
14.2
|
1.0
|
C
|
B:ALA109
|
3.8
|
12.9
|
1.0
|
CA
|
B:ALA109
|
3.9
|
11.9
|
1.0
|
CB
|
B:LEU110
|
3.9
|
11.6
|
1.0
|
O17
|
B:2051001
|
4.0
|
21.0
|
0.5
|
C15
|
B:2051001
|
4.0
|
19.6
|
0.5
|
C13
|
B:2051001
|
4.0
|
20.8
|
0.5
|
O
|
B:SER117
|
4.1
|
13.7
|
1.0
|
C2
|
B:2051001
|
4.3
|
20.8
|
0.5
|
CG2
|
B:THR119
|
4.3
|
11.5
|
0.7
|
O
|
B:ALA109
|
4.3
|
13.6
|
1.0
|
CA
|
B:ALA108
|
4.3
|
14.3
|
1.0
|
CA
|
B:LEU110
|
4.4
|
12.4
|
1.0
|
N
|
B:THR119
|
4.5
|
13.2
|
1.0
|
C14
|
B:2051001
|
4.5
|
20.3
|
0.5
|
C3
|
B:2051001
|
4.6
|
21.0
|
0.5
|
CA
|
B:THR118
|
4.7
|
13.8
|
1.0
|
C
|
B:SER117
|
4.7
|
13.7
|
1.0
|
C
|
B:THR118
|
4.9
|
13.6
|
1.0
|
|
Reference:
H.Razavi,
S.K.Palaninathan,
E.T.Powers,
R.L.Wiseman,
H.E.Purkey,
N.N.Mohamedmohaideen,
S.Deechongkit,
K.P.Chiang,
M.T.Dendle,
J.C.Sacchettini,
J.W.Kelly.
Benzoxazoles As Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action Angew.Chem.Int.Ed.Engl. V. 42 2758 2003.
ISSN: ESSN 0570-0833
PubMed: 12820260
DOI: 10.1002/ANIE.200351179
Page generated: Sat Jul 20 07:00:32 2024
|